Acelyrin, Inc. (SLRN) Tops Q3 EPS by 70c

Acelyrin, Inc. (NASDAQ: SLRN) reported Q3 EPS of ($0.49), $0.70 better than the analyst estimate of ($1.19).

For earnings history and earnings-related data on Acelyrin, Inc. (SLRN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Invesco Mortgage Capital declares $0.12 monthly dividend for June 2026